In case you missed it, President Obama used his State of the Union speech Tuesday night to call for a national “precision medicine” initiative. But, as often happens in these Halloween candy bags of Presidential wish lists, the details were scant.... Read more »
Risk makes for great headlines. I’m guilty as charged. My first column for Xconomy questioned whether biotech venture capitalists were losing relevance, running away from risk in an inherently risky business.
Heading full steam into the new year, there will... Read more »
The word “story” gets ill treatment at events like the J.P. Morgan Healthcare Conference. It often means an elevator pitch from a harried CEO to a distracted investor, or a few observations a journalist strings together with a headline, or Twitter... Read more »
San Diego-based TVC Capital, a small private equity firm that specializes in growth-stage investments in software companies, has closed its third investment fund with $115 million in capital commitments.
All of the firm’s existing institutional investors participated in the fund, TVC... Read more »
Whew. J.P. Morgan is almost over. (The healthcare conference, that is, not the investment bank.)
Opening the week’s proceedings at the Biotech Showcase, a satellite conference that features small, private, often European companies that would get trampled at the main event,... Read more »
Venture capital firms invested more than $47.3 billion in U.S. startups in 2014, marking the highest funding level of VC funding since 2001, according to data being released today by CB Insights, the New York-based venture capital database.
The $47.3... Read more »
The significance of a deal announced last week during the 2015 International CES in Las Vegas went largely unnoticed amid the hubbub of the world’s biggest consumer technology show, packed as it was with 3,600 exhibitors and over 170,000 attendees.
The... Read more »